Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador - Report - MDSpire

Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador

  • By

  • María-Luisa Vázquez

  • Pamela Eguiguren

  • Amparo-Susana Mogollón-Pérez

  • Andrés Peralta

  • Josep M Borràs

  • Ignacio Aznar-Lou

  • Signe Smith Jervelund

  • Carol Cardozo

  • Samar Benthami-Zarhouni

  • Iván Dueñas-Espín

  • María Luisa Garmendia

  • Sónia Dias

  • Ingrid Vargas

  • February 26, 2026

  • 0 min

Share

Barriers and Variations in Cancer Diagnosis in Latin America

Overview

This study analyzes the diagnostic pathways and provider intervals for cancer patients in public health systems of Chile, Colombia, and Ecuador. It highlights significant delays in diagnosis, particularly within the provider interval, which are critical to understanding cancer mortality rates in the region.

Background

Delays in cancer diagnosis and treatment are a major contributor to rising mortality rates in Latin America. The provider interval, which is often longer than the patient interval, reveals systemic inefficiencies that differ from those observed in high-income countries. Understanding these barriers is essential for improving cancer care and outcomes in these fragmented healthcare systems.

Data Highlights

Remove placeholder text and replace with relevant findings or data points from the study.

Key Findings

  • Provider intervals for breast cancer diagnosis range from 60 to 195 days, significantly longer than patient intervals of 10 to 30 days.
  • Diagnostic pathways in Latin America are complex and differ from those in high-income countries, often lacking a clear starting point.
  • Limited access to secondary care and poor coordination across healthcare levels contribute to diagnostic delays.
  • Existing studies on provider intervals primarily focus on breast cancer, with limited research on other cancer types in the region.
  • Integrated care strategies and maximum waiting times have been implemented but show limited effectiveness in reducing diagnostic delays.

Clinical Implications

Healthcare providers should be aware of the significant delays in cancer diagnosis within public health systems in Latin America. Strategies to streamline diagnostic pathways and improve coordination between care levels are essential for enhancing patient outcomes.

Conclusion

Addressing the barriers to timely cancer diagnosis in Latin America is crucial for reducing mortality rates. Continued research and implementation of effective healthcare strategies are necessary to improve patient care in these regions.

References

  1. Delays and detours during cancer diagnosis: a cross-sectional study on patient pathways and provider intervals in public healthcare networks of Chile, Colombia and Ecuador - PMC, 2023
  2. The ASCO Post — How Often Do Patients With Cancer Face Barriers When Attempting to Access Care?
  3. The ASCO Post — Program Aims to Overcome Barriers to Early Cancer Care in Colombia
  4. The ASCO Post — Study Examines Disparities in Access to Cancer Care Among Non–English-Speaking Patients in the United States
  5. the asco post — Global Analysis Uncovers Wide Inequalities in Care for Breast, Cervical, and Ovarian Cancers
  6. How Often Do Patients With Cancer Face Barriers When Attempting to Access Care?
  7. Program Aims to Overcome Barriers to Early Cancer Care in Colombia
  8. Study Examines Disparities in Access to Cancer Care Among Non–English-Speaking Patients in the United States
  9. Delays and detours during cancer diagnosis: a cross-sectional study on patient pathways and provider intervals in public healthcare networks of Chile, Colombia and Ecuador - PMC
  10. AUGE >>85GARANTÍAS DE OPORTUNIDADMinisterio de Sal
  11. Ley 1384 de 2010 - Gestor Normativo

Original Source(s)

Related Content